Why the study?
The study sought to assess the effect on short-term outcomes and long-term survival of using a second arterial conduit (RITA or RA) versus saphenous vein, and to compare RITA versus RA as the second arterial conduit.
Does a second arterial conduit improve short- and long-term outcomes compared to a saphenous vein graft in patients undergoing coronary artery bypass grafting?
Does a second arterial conduit improve short- and long-term outcomes compared to a saphenous vein graft in patients undergoing coronary artery bypass grafting?
The use of a second arterial conduit during CABG is associated with improved long-term survival compared to a saphenous vein graft, with comparable outcomes between radial and right internal thoracic arteries.
Answers are grounded in this paper and cite their sources.
May inform conduit selection in CABG; leaves open randomized confirmation of mortality benefit.
Background: The aim of this study was to assess the effect on short-term outcomes and long-term survival in patients following coronary artery bypass grafting in whom second arterial conduit(right internal thoracic artery-RITA or radial artery-RA) or saphenous vein was grafted and between RITA and RA as second best arterial conduit. Methods: Between January-2006 and June-2018, 7857-patients met the inclusion criteria and were divided into two groups: single internal thoracic artery: SITA+Vein group(n=7140) and 2nd-arterial conduit group(n=717), of these 537-patients received RITA and 180-patients received RA. Short‐term outcomes included: 30-day mortality and Major Adverse Cardiac and Cerebral Events(MACCE), reoperation for bleeding and deep sternal wound infection(DSWI). The long‐term outcome was all‐cause mortality. propensity score(PS) matching was used to match patients between the groups. Results: Before as well as after PS-matching, no significant differences were observed between 2nd-arterial conduit vs SITA+Vein groups and between RITA vs RA groups in terms of 30-day mortality, 30-day MACCE, reoperation for bleeding and incidence of DSWI. The use of 2nd-arterial conduit was associated with a significant reduction in long-term mortality before(HR:0.52;95%CI;0.43-0.64;p<0.001) as well as after PS-matching(HR:0.77;95%CI;0.60-0.99;p=0.04). RA and RITA as second arterial conduit had comparable long-term mortality before(HR:1.22;95%CI;0.82-1.82;p=0.3) as well as after PS-matching(HR:0.96;95%CI;0.58-1.58;p=0.87). Conclusions: The use of 2nd-arterial conduit vs vein is associated with improved long-term survival. As for the 2nd-best arterial conduit, RA and RITA had comparable long-term mortality.
No takes yet. Share an insight, caveat, or question.
Aboul‐Hassan et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: